A troubling case is raising new questions about the reliability of lethal injection as a method of execution. According to a report from The New York Times, Christa Pike reportedly survived not one but two administrations of pentobarbital, the sedative most commonly used in U.S. executions to induce death by stopping breathing and heart function.
Medical and legal experts cited in the report offered two possible explanations. The first centers on the catheter used to deliver the drug into the inmate’s bloodstream. If the line is improperly placed, blocked, or dislodged, the medication may never reach circulation in sufficient quantity to be lethal, even after repeated doses.
The second theory points to the drug itself. Pentobarbital, like many pharmaceutical compounds, can lose potency if it is improperly stored, handled, or has exceeded its stability window. States that carry out executions have faced persistent difficulty sourcing the drug, since many manufacturers refuse to supply it for use in capital punishment, sometimes forcing prison officials to rely on compounding pharmacies with less rigorous quality controls.
The incident is likely to intensify scrutiny of lethal injection protocols, a method already criticized by medical professionals and human rights advocates for inconsistent outcomes. For the full details of this case and expert analysis, read the original report at The New York Times.
Source: How Did Christa Pike Survive Two Lethal Injections of Pentobarbital? (rss.nytimes.com).
Image: nordique, BY 2.0 (via Openverse).